ArticleCancer science2023

Novel specific anti-ESM1 antibodies overcome tumor bevacizumab resistance by suppressing angiogenesis and metastasis.

Nannan Kang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.